Farid Moosavy, MD
Pulmonary Disease · Newark, DENPI 1376594150
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 10 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 8 manufacturers, the largest accounting for just 19.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $232 and has fallen 55.9% since, to $102 in 2024. That places this record below the midpoint for pulmonary disease clinicians in DE, where the typical reported total is $1,477.
Across 10 payments — averaging $61.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$122
- Edwards Lifesciences$117
- La Jolla Pharmaceutical Company$110
- AbbVie$101
- Ceribell, Inc.$83
- Haemonetics Corporation$43
- plus $38 from 2 others
Across 3 payments — averaging $733.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Emergent Biosolutions Inc.$2K
What the payments were for
- Food & beverage$615100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 1 | $122 |
| Edwards Lifesciences | 2 | $117 |
| La Jolla Pharmaceutical Company | 2 | $110 |
| AbbVie | 1 | $101 |
| Ceribell, Inc. | 1 | $83 |
| Haemonetics Corporation | 1 | $43 |
| Mallinckrodt Hospital Products Inc. | 1 | $24 |
| Mylan Specialty L.p. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$615 in reported general payments places this provider in the 35th percentile of 39 pulmonary disease providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Newark
- Albert RizzoNewark$162K
- Haroon RajaNewark$44K
- Ismael MatusNewark$27K
- Naveed HasanNewark$3K
- Theodora FynnNewark$2K
- Sam ThomasNewark$2K
- Irene SwiftNewark$2K
- Donald CollinsNewark$2K
- Sajjad AhmadNewark$749
- Sonali BishnoiNewark$686
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.